The shareholders of generic pharmaceuticals manufacturer Mylan N.V. (NYSE: MYL) have approved the takeover bid for Perrigo Company (NYSE:PRGO; TASE:PRGO) by a clear 65% majority. Mylan N.V. will now submit an official bid. Mylan chairman Robert Coury said, “We look forward to launching our formal offer directly to Perrigo shareholders in the coming weeks, and we are very confident that they too will support this unique and compelling transaction." RELATED ARTICLES Perrigo CEO: Mylan's move shows desperation Mylan might make do with only 50% of Perrigo Perrigo CEO: Mylan will find it hard to buy us Teva CEO: Allergan acquisition a game changer Mylan has bid about $30 billion for Perrigo, which vehemently opposes the takeover. Mylan needs 50% of Perrigo's shares to take control or 80% to own the company outright. Headquartered in Ireland, Perrigo has three manufacturing sites in Israel and is traded on the TASE. Mylan has stated it would not delist Perrigo from the TASE if the takeover goes ahead. Published by Globes [online], Israel business news - www.globes-online.com - on August 28, 2015 © Copyright of Globes Publisher Itonut (1983) Ltd. 2015
